https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:51575 Wed 29 May 2024 15:12:23 AEST ]]> Long-term disability trajectories in primary progressive MS patients: a latent class growth analysis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:36042 Wed 29 Jan 2020 16:35:27 AEDT ]]> The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:39575 Wed 27 Jul 2022 14:43:55 AEST ]]> Automatic and robust segmentation of multiple sclerosis lesions with convolutional neural networks https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:45246 Wed 26 Oct 2022 15:22:01 AEDT ]]> A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:13674 Wed 24 Jun 2020 12:51:30 AEST ]]> Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:33927 Wed 23 Jan 2019 15:30:44 AEDT ]]> Sun exposure across the life course significantly modulates early multiple sclerosis clinical course https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:47544 Wed 22 Mar 2023 15:52:30 AEDT ]]> Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:48348 Wed 14 Feb 2024 15:59:55 AEDT ]]> Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:13696 Wed 11 Apr 2018 12:04:40 AEST ]]> Reduced cognitive function contributes to economic burden of multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:49147 Wed 07 Feb 2024 15:06:36 AEDT ]]> Variation within MBP gene predicts disease course in multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:34728 interaction = 0.05) and relapse (pinteraction = 0.02). Functional prediction analysis showed this variant is the target of many transcription factors and the binding sites of miR-218 and miR-188-3p. Conclusions: Our results provide novel insights into the role of genetic variation within the MBP gene predicting MS clinical course, both directly and by interaction with known environmental MS risk factors.]]> Wed 04 Sep 2019 10:04:21 AEST ]]> Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:43091 Tue 13 Sep 2022 12:26:49 AEST ]]> Prediction of multiple sclerosis outcomes when switching to ocrelizumab https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:46515 Thu 24 Nov 2022 15:50:23 AEDT ]]> Onset symptoms, Tobacco smoking, and progressive-onset phenotype are associated with a delayed onset of multiple sclerosis, and marijuana use with an earlier onset https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:43333 Thu 15 Sep 2022 14:57:26 AEST ]]> Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:52249 Thu 05 Oct 2023 14:07:20 AEDT ]]> Confirmed disability progression as a marker of permanent disability in multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:52212 88% likely to be sustained (events with score ˃1.5). Conclusions: Clinicodemographic characteristics of 6-month confirmed disability progression events identify those at high risk of sustained long-term disability. This knowledge will allow future trials to better assess the effect of therapy on long-term disability accrual.]]> Thu 05 Oct 2023 10:22:58 AEDT ]]> Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:25354 Sat 24 Mar 2018 07:24:42 AEDT ]]> Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:49703 Mon 29 May 2023 13:00:52 AEST ]]> Determinants of therapeutic lag in multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:49695 Mon 29 May 2023 12:46:42 AEST ]]> Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:48108 Mon 27 Feb 2023 15:18:00 AEDT ]]> Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:36719 Mon 24 Aug 2020 10:45:35 AEST ]]> Spiral MRSI and tissue segmentation of normal-appearing white matter and white matter lesions in relapsing remitting multiple sclerosis patients https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:42377 Mon 22 Aug 2022 14:29:24 AEST ]]> Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:51774 Mon 18 Sep 2023 14:29:20 AEST ]]> Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:50986 Mon 14 Aug 2023 15:59:28 AEST ]]> Defining secondary progressive multiple sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:25306 Mon 06 Mar 2023 17:55:37 AEDT ]]> Association of Pregnancy with the Onset of Clinically Isolated Syndrome https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:41083 Fri 22 Jul 2022 17:11:28 AEST ]]> Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:42294 Fri 19 Aug 2022 14:58:38 AEST ]]> Reliability of neurometabolite detection with two-dimensional localized correlation spectroscopy at 3T https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:47224 Fri 16 Dec 2022 10:37:25 AEDT ]]> Developing a clinical-environmental-genotypic prognostic index for relapsing-onset multiple sclerosis and clinically isolated syndrome https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:49201 Fri 05 May 2023 15:58:23 AEST ]]>